Highlight Therapeutics is a clinical-stage biopharmaceutical company.
Highlight Therapeutics has raised $17.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Highlight Therapeutics's investors include Buenavista Equity Partners, Columbus Venture Partners, Centre for the Development of Industrial Technology (CDTI), Advent Life Sciences, Realiza Business Angels.
Highlight Therapeutics is headquartered in Paterna, Spain.
Highlight Therapeutics is a clinical-stage biopharmaceutical company.
Highlight Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Highlight Therapeutics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/highlight-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). Highlight Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/highlight-therapeutics
{{cite web |title=Highlight Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/highlight-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated